These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25650736)

  • 21. Association between Dementia Rating Scale performance and neurocognitive domains in Alzheimer's disease.
    Knox MR; Lacritz LH; Chandler MJ; Munro Cullum C
    Clin Neuropsychol; 2003 May; 17(2):216-9. PubMed ID: 13680428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing motor and cognitive regulation in AD, MCI, and controls using the Behavioral Dyscontrol Scale.
    Belanger HG; Wilder-Willis K; Malloy P; Salloway S; Hamman RF; Grigsby J
    Arch Clin Neuropsychol; 2005 Mar; 20(2):183-9. PubMed ID: 15708728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive and developmental influences in visual-motor integration skills in young children.
    Decker SL; Englund JA; Carboni JA; Brooks JH
    Psychol Assess; 2011 Dec; 23(4):1010-6. PubMed ID: 21707185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validity of the factor structure of Conners' CPT.
    Egeland J; Kovalik-Gran I
    J Atten Disord; 2010 Jan; 13(4):347-57. PubMed ID: 19448149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Memory and attention performance in psychiatric patients: lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results.
    Moritz S; Ferahli S; Naber D
    J Int Neuropsychol Soc; 2004 Jul; 10(4):623-33. PubMed ID: 15327740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in quantitative methods for measuring subjective cognitive decline - results from a prospective memory clinic study.
    Vogel A; Salem LC; Andersen BB; Waldemar G
    Int Psychogeriatr; 2016 Sep; 28(9):1513-20. PubMed ID: 27053171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological Functioning in Veterans with Posttraumatic Stress Disorder: Associations with Performance Validity, Comorbidities, and Functional Outcomes.
    Wrocklage KM; Schweinsburg BC; Krystal JH; Trejo M; Roy A; Weisser V; Moore TM; Southwick SM; Scott JC
    J Int Neuropsychol Soc; 2016 Apr; 22(4):399-411. PubMed ID: 26892753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor tests and cognition in healthy older adults.
    Ashendorf L; Vanderslice-Barr JL; McCaffrey RJ
    Appl Neuropsychol; 2009 Jul; 16(3):171-6. PubMed ID: 20183169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confirmatory factor analysis of the Neurological Evaluation Scale in unmedicated schizophrenia.
    Sanders RD; Allen DN; D Forman S; Tarpey T; Keshavan MS; Goldstein G
    Psychiatry Res; 2005 Jan; 133(1):65-71. PubMed ID: 15698678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organizational strategy use in children aged 5-7: standardization and validity of the Rey Complex Figure Organizational Strategy Score (RCF-OSS).
    Martens R; Hurks PP; Jolles J
    Clin Neuropsychol; 2014; 28(6):954-73. PubMed ID: 25066535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary validation of the French translation of anxiety sensibility index-revised (ASI-R)].
    Bouvard M; Ayxères-Vighetto A; Dupont H; Aupetit J; Portalier S; Arrindell W
    Encephale; 2003; 29(2):157-64. PubMed ID: 14567167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Behavior dyscontrol scale: validation and initial results].
    Hantouche EG; Chignon JM; Adès J
    Encephale; 1992; 18(2):163-70. PubMed ID: 1638998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurological soft signs in psychometrically identified schizotypy.
    Kaczorowski JA; Barrantes-Vidal N; Kwapil TR
    Schizophr Res; 2009 Dec; 115(2-3):293-302. PubMed ID: 19651490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computerized neurocognitive scanning: II. The profile of schizophrenia.
    Gur RC; Ragland JD; Moberg PJ; Bilker WB; Kohler C; Siegel SJ; Gur RE
    Neuropsychopharmacology; 2001 Nov; 25(5):777-88. PubMed ID: 11682261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of exercise dependence in bodybuilders.
    Smith DK; Hale BD; Collins D
    J Sports Med Phys Fitness; 1998 Mar; 38(1):66-74. PubMed ID: 9638035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AULA virtual reality test as an attention measure: convergent validity with Conners' Continuous Performance Test.
    Díaz-Orueta U; Garcia-López C; Crespo-Eguílaz N; Sánchez-Carpintero R; Climent G; Narbona J
    Child Neuropsychol; 2014; 20(3):328-42. PubMed ID: 23638628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construct validity of selected Automated Neuropsychological Assessment Metrics (ANAM) battery measures.
    Kabat MH; Kane RL; Jefferson AL; DiPino RK
    Clin Neuropsychol; 2001 Dec; 15(4):498-507. PubMed ID: 11935451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-analysis of perceptual and cognitive functions involved in useful-field-of-view test performance.
    Woutersen K; Guadron L; van den Berg AV; Boonstra FN; Theelen T; Goossens J
    J Vis; 2017 Dec; 17(14):11. PubMed ID: 29270605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.